8-K

Company

Aurinia Pharmaceuticals Inc.

Filed

June 30, 2025

Period of Report

June 30, 2025

Accession Number

0001600620-25-000083

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →